Yet, serum adiponectin concentrations were mostly low in type 2 diabetics but increased in type 1 diabetics [69,70], indicating the need for further research to evaluate the suitability of urinary adiponectin levels as a predictive biomarker for renal impairment in type 1 diabetes. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.